Concept to Company: An Investigator's Guide to Starting a Business

Event description

Presenter: Steve Flaim, Ph.D., F.A.C.C., F.A.H.A.

The January Catalyze Webinar, "Concept to Company: An investigator's guide to starting a business", was presented by Steve Flaim, Senior Special Advisor and Investor-in-Residence with the Office of Innovation and Commercialization at the National Heart, Lung & Blood Institute and Entrepreneur-in-Residence in the SEED Office on January 25th at 12:00 ET. While there are several paths to market that are available to innovators, startup companies are one of the most popular. Steve has a wealth of knowledge and experience in pharmaceutical research & development, management, and investing potential. Specific topics that Steve discussed included:

  • When and how to form a startup company
  • Key features of investable startup companies
  • Important considerations in developing a pitch deck

There was a Q&A session following the presentation.

Webinar presented on January 25, 2023 to an invited audience.

This video is provided for educational purposes only.

Download slides

Chapters

0:00
Introduction
1:45
Stages of a Company
3:29
When and How to Form a Company Step One – Intellectual Property (IA)
7:00
When and How to Form a Company Step Two – Company Formation
11:00
When and How to Form a Company Step Three – Licensing Agreement
12:18
When and How to Form a Company Step Four – Funding
13:20
Capital Sources – Over the Startup Lifecycle
15:10
Capital Amounts Invested
15:53
Angels vs Venture Capital
16:40
What Do Angels Look For
18:35
Fundable Management Teams
19:56
Size of the Opportunity
20:55
Product and Technology
21:35
Intellectual Property
22:07
Marketing and Sales
22:45
Non-Disclosure Agreements (NDAs)
25:03
Pitch Decks - Key Points to Consider
30:22
Title Slide
31:43
Define Problem
32:10
Your Solution
33:27
The Market Opportunity
34:32
Competitive Analysis
35:55
Barriers to Entry
37:24
Project Plan to Exit
38:57
Team
40:33
Summary Slide
42:07
Questions and Answers
This research was, in part, funded by the National Institutes of Health (NIH) Agreement OT2 HL157844-01. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH.